Atomistry » Zinc » PDB 6uco-6uo7 » 6ugy
Atomistry »
  Zinc »
    PDB 6uco-6uo7 »
      6ugy »

Zinc in PDB 6ugy: Crystal Structure of the Fc Fragment of Anti-Tnfa Antibody Infliximab (Remicade) in A Primative Orthorhombic Crystal Form, Lot C

Protein crystallography data

The structure of Crystal Structure of the Fc Fragment of Anti-Tnfa Antibody Infliximab (Remicade) in A Primative Orthorhombic Crystal Form, Lot C, PDB code: 6ugy was solved by S.J.Mayclin, T.E.Edwards, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 50.00 / 2.10
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 50.340, 148.650, 75.980, 90.00, 90.00, 90.00
R / Rfree (%) 17.9 / 22.8

Zinc Binding Sites:

The binding sites of Zinc atom in the Crystal Structure of the Fc Fragment of Anti-Tnfa Antibody Infliximab (Remicade) in A Primative Orthorhombic Crystal Form, Lot C (pdb code 6ugy). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total 3 binding sites of Zinc where determined in the Crystal Structure of the Fc Fragment of Anti-Tnfa Antibody Infliximab (Remicade) in A Primative Orthorhombic Crystal Form, Lot C, PDB code: 6ugy:
Jump to Zinc binding site number: 1; 2; 3;

Zinc binding site 1 out of 3 in 6ugy

Go back to Zinc Binding Sites List in 6ugy
Zinc binding site 1 out of 3 in the Crystal Structure of the Fc Fragment of Anti-Tnfa Antibody Infliximab (Remicade) in A Primative Orthorhombic Crystal Form, Lot C


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Crystal Structure of the Fc Fragment of Anti-Tnfa Antibody Infliximab (Remicade) in A Primative Orthorhombic Crystal Form, Lot C within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn501

b:28.3
occ:1.00
O A:HOH648 2.0 31.3 1.0
NE2 A:HIS313 2.0 30.6 1.0
NE2 A:HIS438 2.0 24.9 1.0
O A:ACT504 2.2 37.8 1.0
OXT A:ACT504 2.2 46.8 1.0
C A:ACT504 2.4 49.1 1.0
CE1 A:HIS313 2.9 23.4 1.0
CD2 A:HIS438 3.0 24.0 1.0
CE1 A:HIS438 3.0 22.2 1.0
CD2 A:HIS313 3.1 26.6 1.0
O A:HOH717 3.1 37.7 1.0
CH3 A:ACT504 3.7 49.1 1.0
CD1 A:LEU317 3.8 28.1 1.0
ND1 A:HIS313 4.1 23.1 1.0
ND1 A:HIS438 4.1 22.5 1.0
CG A:HIS438 4.2 25.5 1.0
CG A:HIS313 4.2 30.7 1.0

Zinc binding site 2 out of 3 in 6ugy

Go back to Zinc Binding Sites List in 6ugy
Zinc binding site 2 out of 3 in the Crystal Structure of the Fc Fragment of Anti-Tnfa Antibody Infliximab (Remicade) in A Primative Orthorhombic Crystal Form, Lot C


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 2 of Crystal Structure of the Fc Fragment of Anti-Tnfa Antibody Infliximab (Remicade) in A Primative Orthorhombic Crystal Form, Lot C within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn502

b:46.9
occ:0.77
O A:HOH626 1.8 34.0 1.0
O A:HOH723 2.0 42.1 1.0
ND1 A:HIS288 2.4 54.6 1.0
CG A:HIS288 3.2 54.9 1.0
CB A:HIS288 3.3 59.0 1.0
CE1 A:HIS288 3.5 59.5 1.0
CA A:HIS288 3.9 53.7 1.0
O A:HOH627 4.2 42.1 1.0
CD2 A:HIS288 4.4 55.2 1.0
NE2 A:HIS288 4.5 59.3 1.0
O A:HIS288 4.5 51.0 1.0
OE1 A:GLU286 4.5 55.5 1.0
C A:HIS288 4.7 56.7 1.0
O A:VAL287 4.8 57.7 1.0
O A:HOH675 5.0 39.4 1.0
N A:HIS288 5.0 52.0 1.0

Zinc binding site 3 out of 3 in 6ugy

Go back to Zinc Binding Sites List in 6ugy
Zinc binding site 3 out of 3 in the Crystal Structure of the Fc Fragment of Anti-Tnfa Antibody Infliximab (Remicade) in A Primative Orthorhombic Crystal Form, Lot C


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 3 of Crystal Structure of the Fc Fragment of Anti-Tnfa Antibody Infliximab (Remicade) in A Primative Orthorhombic Crystal Form, Lot C within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn503

b:75.0
occ:0.48
OE1 A:GLU321 2.4 80.8 1.0
O A:HOH653 2.5 74.0 1.0
OE2 A:GLU321 2.5 84.9 1.0
CD A:GLU321 2.7 75.4 1.0
CG A:GLU321 4.2 58.2 1.0
CB A:GLU321 4.8 42.9 1.0
CG2 A:THR338 4.9 40.0 1.0

Reference:

T.F.Lerch, P.Sharpe, S.J.Mayclin, T.E.Edwards, S.Polleck, J.C.Rouse, Q.Zou, H.D.Conlon. Crystal Structures of Pf-06438179/GP1111, An Infliximab Biosimilar. Biodrugs 2019.
ISSN: ISSN 1179-190X
PubMed: 31650490
DOI: 10.1007/S40259-019-00390-1
Page generated: Tue Oct 29 08:36:33 2024

Last articles

Fe in 8Z83
Fe in 8ZBD
Fe in 8Z9S
Fe in 8Z1Z
Fe in 8Z4Q
Fe in 8YS5
Fe in 8Z1Y
Fe in 8Z1X
Fe in 8Z11
Fe in 8Z1W
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy